Literature DB >> 30639802

Neighbourhood influence on the fourth dose of diphtheria-tetanus-pertussis vaccination.

S T Hegde1, A L Wagner2, P J Clarke3, R C Potter4, R G Swanson5, M L Boulton6.   

Abstract

OBJECTIVES: Using 542,159 vaccination records from children born between April 1, 2007, and March 31, 2012, in the Michigan Care Improvement Registry and data from the American Community Survey, we determine if neighbourhood-level characteristics at the Census tract level and block level are associated with low uptake of the fourth dose of diphtheria-tetanus-acellular pertussis vaccine (DTaP4). STUDY
DESIGN: This study was a cross-sectional study.
METHODS: We used exploratory factor analysis to determine important socio-economic factors at the Census block level and tract level. We then used generalised estimating equations to test the relationship between block- and tract-level socio-economic factors and DTaP4 uptake.
RESULTS: DTaP4 coverage was 88.6% (95% confidence interval [CI]: 88.4%-88.7%) in Michigan. At the Census tract level, two factors surfaced as important for DTaP4 vaccination: 'affluence' (Cronbach's alpha = 0.88) and 'socio-economic disadvantage' (Cronbach's alpha = 0.89). At the Census block level, one factor was important: 'affluence' (Cronbach's alpha = 0.90). Affluence may relate to knowledge about medical exemptions and antivaccination sentiment, while socio-economic disadvantage may indicate limited access to healthcare resources. Children in high-affluence tracts had 1.08% lower vaccination coverage (95% CI: -1.62% to -0.55%) than children in low affluence tracts. Children in low socio-economic disadvantage tracts had 2.92% higher coverage than children in high socio-economic disadvantage tracts (95% CI: 2.58%-3.26%).
CONCLUSIONS: This study articulates the need to further understand the contribution of neighbourhood-level characteristics, from both affluent and socioeconomically disadvantaged areas to low vaccination rates. Developing a better understanding of these social environmental factors will help determine useful community-level interventions to improve vaccination rates and reduce disease burden.
Copyright © 2018 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diphtheria; Neighbourhood; Pertussis; Social epidemiology; Vaccine hesitancy

Mesh:

Substances:

Year:  2019        PMID: 30639802     DOI: 10.1016/j.puhe.2018.11.009

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


  5 in total

1.  [Geographic analyses as a foundation for evidence-based public health interventions: the example identification and typology of risk clusters for mumps, measles, and rubella].

Authors:  Sebastian Völker; Reinhard Hammerschmidt; Anke Spura
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2021-04-23       Impact factor: 1.513

2.  Variation in COVID-19 booster uptake in England: An ecological study.

Authors:  Greg Dropkin
Journal:  PLoS One       Date:  2022-06-29       Impact factor: 3.752

3.  General attitudes toward and awareness of vaccines among students at a university in Northern Cyprus.

Authors:  Nilufer Guzoglu; Zahra Daneshvar; Elmira Hamrang; Ilayda Deniz Kayisbudak; Hayel Khasawneh; Omar Yasser Mahmoud; Abeer Mohammad Sani; Gorkem Sokmen
Journal:  Hum Vaccin Immunother       Date:  2021-03-15       Impact factor: 3.452

4.  Vaccine Hesitancy and Rejection of a Vaccine for the Novel Coronavirus in the United States.

Authors:  Shu-Fang Shih; Abram L Wagner; Nina B Masters; Lisa A Prosser; Yihan Lu; Brian J Zikmund-Fisher
Journal:  Front Immunol       Date:  2021-06-14       Impact factor: 7.561

5.  Evaluation of a city-wide school-located influenza vaccination program in Oakland, California with respect to race and ethnicity: A matched cohort study.

Authors:  Anna T Nguyen; Benjamin F Arnold; Chris J Kennedy; Kunal Mishra; Nolan N Pokpongkiat; Anmol Seth; Stephanie Djajadi; Kate Holbrook; Erica Pan; Pam D Kirley; Tanya Libby; Alan E Hubbard; Arthur Reingold; John M Colford; Jade Benjamin-Chung
Journal:  Vaccine       Date:  2021-12-03       Impact factor: 3.641

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.